AstraZeneca
AZN
#48
Rank
$281.06 B
Marketcap
$90.65
Share price
0.92%
Change (1 day)
35.00%
Change (1 year)

AstraZeneca (AZN) - Cash on Hand

Cash on Hand as of September 2025 : $8.18 Billion USD

According to AstraZeneca's latest financial reports the company has $8.18 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AstraZeneca - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$5.52 B-5.72%
2023-12-31$5.86 B-6.13%
2022-12-31$6.24 B-2.42%
2021-12-31$6.39 B-19.94%
2020-12-31$7.99 B28.55%
2019-12-31$6.21 B11.14%
2018-12-31$5.59 B22.84%
2017-12-31$4.55 B-21.63%
2016-12-31$5.81 B-13.82%
2015-12-31$6.74 B-4.23%
2014-12-31$7.04 B-28.84%
2013-12-31$9.89 B20.32%
2012-12-31$8.22 B-27.08%
2011-12-31$11.27 B-4.64%
2010-12-31$11.82 B3.71%
2009-12-31$11.40 B159.67%
2008-12-31$4.39 B-26.3%
2007-12-31$5.95 B-22.46%
2006-12-31$7.68 B54.33%
2005-12-31$4.97 B-5.43%
2004-12-31$5.26 B33.26%
2003-12-31$3.95 B-15.72%
2002-12-31$4.68 B22.63%
2001-12-31$3.82 B-14.14%
2000-12-31$4.45 B35.41%
1999-12-31$3.28 B-3.63%
1998-12-31$3.41 B183.13%
1997-12-31$1.20 B-27.82%
1996-12-31$1.66 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Bristol-Myers Squibb
BMY
$16.50 B 101.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$14.98 B 83.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$18.21 B 122.61%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$4.44 B-45.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
$10.45 B 27.74%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
$9.91 B 21.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$18.56 B 126.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$7.73 B-5.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$3.96 B-51.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$9.75 B 19.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland